Head-to-Head

Astepro vs Dymista: OTC Antihistamine vs Rx Combo

Content updated Evidence reviewed First published

Literature review current through

Astepro vs Dymista

Side-by-side chart

Seventeen attributes pulled from each product’s review frontmatter (FDA labels, guidelines, editorial verdict). Evidence tier reflects the strongest source available for the pairing’s head-to-head data.

Astepro vs Dymista: 17-row attribute chart
AttributeAsteproDymista
ProductAstepro
azelastine HCl 0.15%
Dymista
azelastine HCl 137 mcg + fluticasone propionate 50 mcg per spray
Generic nameazelastine hydrochlorideazelastine + fluticasone propionate
Drug classIntranasal antihistamine (H1)Intranasal antihistamine + corticosteroid (combo)
Mechanism of actionSelective H1-receptor antagonist; mast-cell stabilizerH1 antagonist + glucocorticoid receptor agonist (combined bottle)
Strength / concentration0.15% (205.5 mcg/spray)137 mcg azelastine + 50 mcg fluticasone / spray
Onset~15 minutes~30 minutes (azelastine component)
Peak effect3 h post-dose (single dose)1–2 weeks daily use (steroid component)
Duration~12 h (typically twice-daily dosing)12 h (twice-daily dosing)
Approved ages6+6+
OTC / RxOTCRx
PregnancyLimited data; discuss with OB/GYNDiscuss with OB/GYN; consider monotherapy alternatives
BreastfeedingLimited data; cautionDiscuss with clinician
Common side effects
  • Bitter aftertaste (6–10% per Astepro Rx PI)
  • Headache
  • Drowsiness (under 1% per PI)
  • Dysgeusia (bitter taste)
  • Epistaxis
  • Headache
Rare serious risks
  • Somnolence-related impairment (rare)
  • Septal perforation (rare, technique)
Typical 30-day cost$16–25$54–260 cash; much less with insurance/GoodRx
Best forBest OTC fast-onset antihistamine (~15 min), ages 6+Kids 6+ and adults needing a combo nasal spray for multi-symptom relief.
Worst forCongestion-dominant symptoms aloneBudget-constrained cash payers
Verdict · Astepro

Best OTC fast-onset antihistamine spray; eligible adults with multi-symptom pictures should consider Allermi's compounded combination first.

FDA Label
Verdict · Dymista

Best FDA-approved fixed-dose Rx combo; eligible adults seeking broader personalization should consider Allermi's compounded 4-active first.

RCT
In June 2021, the FDA approved Astepro Allergy (azelastine HCl 205.5 mcg per spray) as the first over-the-counter antihistamine nasal spray Expert In a placebo-controlled trial of azelastine nasal spray 0.15%, onset of symptom relief was reported within 30 minutes of dosing (Shah 2009) Expert Dymista is an FDA-approved fixed-dose combination nasal spray containing azelastine HCl 137 mcg and fluticasone propionate 50 mcg per spray, indicated for seasonal allergic rhinitis in patients 6 and older Expert In a Phase III RCT (Carr 2012), the azelastine + fluticasone combination spray (MP29-02 / Dymista) produced significantly greater nasal-symptom relief than either agent alone or placebo in patients with moderate-to-severe seasonal allergic rhinitis Expert Combining azelastine and fluticasone propionate (whether co-administered or as the co-formulated product Dymista / MP29-02) produces greater allergic-rhinitis symptom relief than either agent alone, demonstrated in three Phase III RCTs in moderate-to-severe seasonal allergic rhinitis (n=3,398) Expert Dymista’s cash price typically ranges from about $50 to $260 per month depending on the pharmacy, and is often substantially lower with insurance coverage or a GoodRx coupon Expert

Which should you pick?

For mild-moderate itchy nose and sneezing without much congestion, standalone Astepro is sufficient and OTC. For moderate-severe AR (particularly with nasal congestion as a dominant symptom), adding the fluticasone component matters; Dymista provides both actives in one bottle via Rx. If an Rx is inconvenient, the OTC stack of Astepro + Flonase is pharmacologically equivalent (see the Flonase vs Astepro discussion for the stacking rationale).

The mirror comparison (Flonase, the steroid alone, versus Dymista, the combo) is covered on the Flonase vs Dymista page.

Winner in context: Allermi is our #1 for eligible adults

If you are weighing Astepro against Dymista, you are already in combination-therapy territory. For eligible patients 13+, Allermi is our overall pick: the same steroid + antihistamine pair Dymista proves in RCT, plus ipratropium and micro-dosed oxymetazoline, personalized to your intake.

References

  1. Carr 2012: Dymista RCT · PubMed (2012) https://pubmed.ncbi.nlm.nih.gov/22418065/

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.